Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunological aspects of 'fulminant type 1 diabetes'.
Nagata M, Moriyama H, Kotani R, Yasuda H, Kishi M, Kurohara M, Hara K, Yokono K. Nagata M, et al. Among authors: kishi m. Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S99-103. doi: 10.1016/j.diabres.2007.01.041. Epub 2007 May 2. Diabetes Res Clin Pract. 2007. PMID: 17478003
Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M, Yasuda H, Moriyama H, Yamada K, Kotani R, Kurohara M, Okumachi Y, Kishi M, Arai T, Hara K, Hamada H, Yokono K, Nagata M. Sakata M, et al. Among authors: kishi m. Diabetes Res Clin Pract. 2008 Jun;80(3):352-9. doi: 10.1016/j.diabres.2008.01.030. Epub 2008 Apr 8. Diabetes Res Clin Pract. 2008. PMID: 18400329
One amino acid difference is critical for suppression of the development of experimental autoimmune diabetes (EAD) with intravenous injection of insulinB:9-23 peptide.
Okumachi Y, Moriyama H, Kameno M, Arai T, Kishi M, Kurohara M, Yamada K, Yasuda H, Hara K, Yokono K, Nagata M. Okumachi Y, et al. Among authors: kishi m. Biochem Biophys Res Commun. 2008 Sep 26;374(3):581-6. doi: 10.1016/j.bbrc.2008.07.066. Epub 2008 Jul 21. Biochem Biophys Res Commun. 2008. PMID: 18647597
Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study.
Otowa-Suematsu N, Sakaguchi K, Nakamura T, Hara K, Kishi M, Hashimoto N, Yokota K, Yoshino H, Kuroki Y, Nishiumi T, Sou A, Komada H, Okada Y, Hirota Y, Tamori Y, Ogawa W. Otowa-Suematsu N, et al. Among authors: kishi m. Diabetes Ther. 2018 Oct;9(5):2067-2079. doi: 10.1007/s13300-018-0505-2. Epub 2018 Sep 11. Diabetes Ther. 2018. PMID: 30206903 Free PMC article.
Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open-label study (SOAR-KOBE Study).
Miura H, Sakaguchi K, Okada Y, Yamada T, Otowa-Suematsu N, So A, Komada H, Hirota Y, Ohara T, Kuroki Y, Hara K, Matsuda T, Kishi M, Takeda A, Yokota K, Tamori Y, Ogawa W. Miura H, et al. Among authors: kishi m. J Diabetes Investig. 2019 Sep;10(5):1254-1261. doi: 10.1111/jdi.13015. Epub 2019 Mar 28. J Diabetes Investig. 2019. PMID: 30688412 Free PMC article.
656 results